Natixis’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.2K | Buy |
+44,280
| New | +$76.2K | ﹤0.01% | 829 |
|
|
2023
Q3 | – | Sell |
-15,989
| Closed | -$113K | – | 1048 |
|
|
2023
Q2 | $113K | Buy |
15,989
+14,949
| +1,437% | +$105K | ﹤0.01% | 777 |
|
|
2023
Q1 | $6.35K | Hold |
1,040
| – | – | ﹤0.01% | 897 |
|
|
2022
Q4 | $6.65K | Buy |
+1,040
| New | +$6.65K | ﹤0.01% | 952 |
|
|
2022
Q2 | – | Sell |
-143,040
| Closed | -$2.38M | – | 1149 |
|
|
2022
Q1 | $2.38M | Buy |
+143,040
| New | +$2.38M | 0.01% | 714 |
|
|
2021
Q3 | – | Sell |
-11,131
| Closed | -$290K | – | 1242 |
|
|
2021
Q2 | $290K | Buy |
+11,131
| New | +$290K | ﹤0.01% | 787 |
|